Viewing StudyNCT05009030



Ignite Creation Date: 2024-05-06 @ 4:29 PM
Last Modification Date: 2024-10-26 @ 2:11 PM
Study NCT ID: NCT05009030
Status: COMPLETED
Last Update Posted: 2022-07-29
First Post: 2021-08-10

Brief Title: Anti-SARS-COV2 Vaccination Study in Lung Cancer Patients
Sponsor:
Organization: Fundación GECP

Study Design

Study Type: OBSERVATIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: False
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 794
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Name
Cohort
Time Perspective List:

Clinical Trial Statuses

Name
78080
Who Masked List: